Investors Eye Turning Point Brands, Canopy Growth, Indivior

As of June 9, 2025, investors are focusing on three notable cannabis stocks: Turning Point Brands, Canopy Growth, and Indivior, as indicated by MarketBeat’s stock screener tool. These stocks represent companies involved in various aspects of the cannabis industry, including cultivation, manufacturing, and distribution for both medical and recreational uses.

Turning Point Brands (TPB). Turning Point Brands, Inc. is a significant player in the cannabis sector, with operations divided into three segments: Zig-Zag Products, Stoker’s Products, and Creative Distribution Solutions. The Zig-Zag segment is particularly well-known for its rolling papers, tubes, and accessories. On June 9, shares of Turning Point Brands traded at $77.42, a $1.27 increase during mid-day trading. Approximately 244,281 shares exchanged hands, surpassing the average volume of 217,352 shares. The company reported a market capitalization of $1.39 billion and a price-to-earnings ratio of 30.74. Its 52-week trading range has fluctuated between $30.61 and $81.05.

Canopy Growth (CGC). Canopy Growth Corporation operates globally, producing and selling cannabis and hemp products primarily in the U.S., Canada, and Germany. The company has segmented its operations into Canada Cannabis, International Markets Cannabis, and Storz & Bickel. On the same day, shares of Canopy Growth traded down to $1.62, a decrease of $0.09, with a trading volume of 7,559,891 shares, which is above its average of 5,945,924 shares. Canopy Growth holds a market cap of $296.94 million, with a price-to-earnings ratio of -0.43. Its stock has had a 52-week low of $0.77 and a high of $8.65.

Indivior (INDV). Indivior PLC focuses on developing and selling medications for opioid dependence and related disorders. The company’s stock was down by $0.14 on June 9, trading at $13.93 with a total volume of 564,680 shares, below its average of 1,078,595 shares. Indivior’s market capitalization stands at $1.92 billion, with a price-to-earnings ratio of -39.81. The stock has fluctuated between $7.33 and $17.09 over the past year.

These stocks have demonstrated the highest dollar trading volume among cannabis-related equities recently, attracting investor attention amidst the ongoing evolution of the cannabis market. Investors should consider the unique risks and opportunities associated with these companies as they navigate the complexities of this rapidly changing sector.